NYSE: EBS - Emergent BioSolutions Inc.

Rentabilidad a seis meses: -24.45%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Noticias Telegrama

J&J COVID-19 vaccine manufacturing halted at US plant that had contamination issue

18 noviembre 19:18 J&J COVID-19 vaccine manufacturing halted at US plant that had contamination issue